Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 9, 2011 - Issue 12
Submit an article Journal homepage
35
Views
7
CrossRef citations to date
0
Altmetric
Theme: General - Review

Renin–angiotensin system blockade and reduction of cardiovascular risk: future perspectives

Alejandro de la Sierra Department of Internal Medicine, Hospital Mutua Terrassa, Plaza Dr Robert 5, 08021 Terrassa, Spain. [email protected]
Pages 1585-1591 | Published online: 10 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Manuel Gorostidi & Alejandro de la Sierra. (2018) Combination therapies for hypertension – why we need to look beyond RAS blockers. Expert Review of Clinical Pharmacology 11:9, pages 841-853.
Read now

Articles from other publishers (6)

Shoko Takahashi, Yoichi Ii, Yuji Yamamoto, Aya Ikeda & Yoko Fujimoto. (2019) Database Analysis of Eplerenone Use in Japanese Hypertensive Patients in Clinical Practice. International Journal of Hypertension 2019, pages 1-6.
Crossref
Juan Wang, Wen He, Liping Guo, Yin Zhang, Hui Li, Suxia Han & Difei Shen. (2017) The ACE2-Ang (1–7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction. Molecular Medicine Reports 16:2, pages 1973-1981.
Crossref
Alejandro de la Sierra, Vivencio Barrios & Diego Gonzalez-Segura. (2013) Control de la presión arterial en unidades hospitalarias de referencia en España. Medicina Clínica 141:2, pages 47-52.
Crossref
Rhian M. Touyz. (2013) Combination Antihypertensive Treatment With Aliskiren and Blockers of the Renin-Angiotensin System—Reassurance but With a Note of Caution. Canadian Journal of Cardiology 29:5, pages 521-523.
Crossref
Manuel Gorostidi & Alejandro de la Sierra. (2013) Combination Therapy in Hypertension. Advances in Therapy 30:4, pages 320-336.
Crossref
Alejandro de la Sierra & Massimo Volpe. (2013) Olmesartan-based therapies. Journal of Hypertension 31:Supplement 1, pages S13-S17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.